Search Results - "de Groot, B"

Alchemical absolute protein-ligand binding free energies for drug design by Khalak, Y, Tresadern, G, Aldeghi, M, Baumann, H. M, Mobley, D. L, de Groot, B. L, Gapsys, V

“…The recent advances in relative protein-ligand binding free energy calculations have shown the value of alchemical methods in drug discovery. Accurately…”
Get full text

Cold plasma treatment for cotton seed germination improvement by de Groot, Gerard J. J. B., Hundt, Andy, Murphy, Anthony B., Bange, Michael P., Mai-Prochnow, Anne

“…Adverse environmental conditions at planting, such as cold temperature or water limitation, can lead to a reduced level of seed germination and plant…”
Get full text

The Dutch version of the Knee Injury and Osteoarthritis Outcome Score: a validation study by de Groot, Ingrid B, Favejee, Marein M, Reijman, Max, Verhaar, Jan A N, Terwee, Caroline B

“…The Knee Injury and Osteoarthritis Outcome Score (KOOS) was constructed in Sweden. This questionnaire has proved to be valid for several orthopedic…”
Get full text

Rapid stress system drives chemical transfer of fear from sender to receiver by de Groot, Jasper H B, Smeets, Monique A M, Semin, Gün R

“…Humans can register another person's fear not only with their eyes and ears, but also with their nose. Previous research has demonstrated that exposure to body…”
Get full text

Diagnostic and societal impact of implementing the syncope guidelines of the European Society of Cardiology (SYNERGY study) by Ghariq, M, van den Hout, W. B, Dekkers, O. M, Bootsma, M, de Groot, B, Groothuis, J. G. J, Harms, M. P. M, Hemels, M. E. W, Kaal, E. C. A, Koomen, E. M, de Lange, F. J, Peeters, S. Y. G, van Rossum, I. A, Rutten, J. H. W, van Zwet, E. W, van Dijk, J. G, Thijs, R. D, Tuinema, R. M, Voet, W, Boerman, D. B, Firouzi, M, Fokke, C

“…Abstract Background Syncope management is fraught with unnecessary tests and frequent failure to establish a diagnosis. We evaluated the potential of…”
Get full text

A Sniff of Happiness by de Groot, Jasper H. B., Smeets, Monique A. M., Rowson, Matt J., Bulsing, Patricia J., Blonk, Cor G., Wilkinson, Joy E., Semin, Gün R.

“…It is well known that feelings of happiness transfer between individuals through mimicry induced by vision and hearing. The evidence is inconclusive, however,…”
Get full text

Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial by Dummer, Reinhard, Ascierto, Paolo A, Gogas, Helen J, Arance, Ana, Mandala, Mario, Liszkay, Gabriella, Garbe, Claus, Schadendorf, Dirk, Krajsova, Ivana, Gutzmer, Ralf, Chiarion-Sileni, Vanna, Dutriaux, Caroline, de Groot, Jan Willem B, Yamazaki, Naoya, Loquai, Carmen, Moutouh-de Parseval, Laure A, Pickard, Michael D, Sandor, Victor, Robert, Caroline, Flaherty, Keith T

“…Combined BRAF-MEK inhibitor therapy is the standard of care for BRAFV600-mutant advanced melanoma. We investigated encorafenib, a BRAF inhibitor with unique…”
Get full text

A Fresh Look on Old Clothes: Laundry Smell Boosts Second-Hand Store Sales by de Groot, Jasper H. B., Walther, Charly, Holland, Rob W.

“…The clothing industry is one of the biggest polluters impacting the environment. Set in a sustainable environment, this study addresses whether certain ambient…”
Get full text

Prospective practice survey of management of cetuximab-related skin reactions by Lugtenberg, R. T., Boers-Doets, C. B., Witteveen, P. O., van Herpen, C. M. L., Wymenga, A. N. M., de Groot, J. W. B., Hoeben, A., del Grande, C., van Doorn, B., Koldenhof, J. J., Driessen, C. M. L., Gelderblom, H.

“…Purpose Evidence-based guidelines on how to prevent or treat cetuximab-related skin reactions are lacking and multiple care and management strategies are used…”
Get full text

Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multicentre, open-label, randomised, phase 3 trial by Dummer, Reinhard, Ascierto, Paolo A, Gogas, Helen J, Arance, Ana, Mandala, Mario, Liszkay, Gabriella, Garbe, Claus, Schadendorf, Dirk, Krajsova, Ivana, Gutzmer, Ralf, Chiarion Sileni, Vanna, Dutriaux, Caroline, de Groot, Jan Willem B, Yamazaki, Naoya, Loquai, Carmen, Moutouh-de Parseval, Laure A, Pickard, Michael D, Sandor, Victor, Robert, Caroline, Flaherty, Keith T

“…Encorafenib plus binimetinib and encorafenib alone improved progression-free survival compared with vemurafenib in patients with BRAFV600-mutant melanoma in…”
Get full text

Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600–mutant melanoma by Ascierto, Paolo A., Dummer, Reinhard, Gogas, Helen J., Flaherty, Keith T., Arance, Ana, Mandala, Mario, Liszkay, Gabriella, Garbe, Claus, Schadendorf, Dirk, Krajsova, Ivana, Gutzmer, Ralf, de Groot, Jan Willem B., Loquai, Carmen, Gollerkeri, Ashwin, Pickard, Michael D., Robert, Caroline

“…BRAF/MEK inhibitor combinations are established treatments for BRAF V600–mutant melanoma based on demonstrated benefits on progression-free survival (PFS) and…”
Get full text

EEG Beta Power but Not Background Music Predicts the Recall Scores in a Foreign-Vocabulary Learning Task by Küssner, Mats B, de Groot, Annette M B, Hofman, Winni F, Hillen, Marij A

“…As tantalizing as the idea that background music beneficially affects foreign vocabulary learning may seem, there is-partly due to a lack of theory-driven…”
Get full text

The Effects of Four Different Tyrosine Kinase Inhibitors on Medullary and Papillary Thyroid Cancer Cells by Verbeek, Hans H. G, Alves, Maria M, de Groot, Jan-Willem B, Osinga, Jan, Plukker, John T. M, Links, Thera P, Hofstra, Robert M. W

“…Tyrosine kinase inhibitor therapy for medullary and papillary thyroid carcinoma is mutation specific, with XL184 being the most potent inhibitor in MEN2A and…”
Get full text

Sex, Gender and Age Differences in Treatment Allocation and Survival of Patients With Metastatic Pancreatic Cancer: A Nationwide Study by Pijnappel, Esther N, Schuurman, Melinda, Wagner, Anna D, de Vos-Geelen, Judith, van der Geest, Lydia G M, de Groot, Jan-Willem B, Koerkamp, Bas Groot, de Hingh, Ignace H J T, Homs, Marjolein Y V, Creemers, Geert-Jan, Cirkel, Geert A, van Santvoort, Hjalmar C, Busch, Olivier R, Besselink, Marc G, van Eijck, Casper H J, Wilmink, Johanna W, van Laarhoven, Hanneke W M

“…Biological sex, gender and age have an impact on the incidence and outcome in patients with metastatic pancreatic cancer. The aim of this study is to…”
Get full text

Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases by de Groot, Jan Willem B, Rikhof, Bart, van Doorn, Jaap, Bilo, Henk J G, Alleman, Maarten A, Honkoop, Aafke H, van der Graaf, Winette T A

“…This review focuses on the tumour types and symptoms associated with non-islet cell tumour-induced hypoglycaemia (NICTH) as well as the pathogenesis, diagnosis…”
Get full text

Effects of Stimulus Characteristics and Background Music on Foreign Language Vocabulary Learning and Forgetting by de Groot, Annette M. B.

“…This study examined the effects of three stimulus variables and background music on paired‐associate learning of foreign language (FL) vocabulary. The stimulus…”
Get full text

Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study by Leicher, Laura W., de Graaf, Jacques C., Coers, Wilko, Tascilar, Metin, de Groot, Jan Willem B.

“…Background Capecitabine monotherapy is a treatment option for selected patients with metastatic colorectal cancer (mCRC) and is administered to up to 17% of…”
Get full text

A plate reader-based method for cell water permeability measurement by Fenton, R A, Moeller, H B, Nielsen, S, de Groot, B L, Rützler, M

“…Cell volume and water permeability measurements in cultured mammalian cells are typically conducted under a light microscope. Many of the employed approaches…”
Get more information

Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study by van der Sijde, Fleur, Homs, Marjolein Y V, van Bekkum, Marlies L, van den Bosch, Thierry P P, Bosscha, Koop, Besselink, Marc G, Bonsing, Bert A, de Groot, Jan Willem B, Karsten, Thomas M, Groot Koerkamp, Bas, Haberkorn, Brigitte C M, Luelmo, Saskia A C, Mekenkamp, Leonie J M, Mustafa, Dana A M, Wilmink, Johanna W, van Eijck, Casper H J, Vietsch, Eveline E, On Behalf Of The Dutch Pancreatic Cancer Group

“…In this study, we explored the predictive value of serum microRNA (miRNA) expression for early tumor progression during FOLFIRINOX chemotherapy and its…”
Get full text

Human Fear Chemosignaling: Evidence from a Meta-Analysis by de Groot, Jasper H B, Smeets, Monique A M

“…Alarm pheromones are widely used in the animal kingdom. Notably, there are 26 published studies (N = 1652) highlighting a human capacity to communicate fear,…”
Get full text